Abstract

This article explores FemTech’s role in addressing gender inequalities in healthcare, with a focus on its implications for feminist legal scholarship. While FemTech is often framed as a movement aimed at democratising women’s healthcare, the article argues that it operates primarily as a financial asset market, prioritising profitability over health equity. Using consumer protection law as a case study, the article examines how consumer access to FemTech markets is shaped by the interests of private investors, such as asset managers and venture capitalists, rather than by concerns for gender health justice. It reveals how FemTech markets enable profitable, scalable healthcare solutions while neglecting health needs that are more marginal and less lucrative. This raises urgent legal questions about the regulation of healthcare technology markets, where access and use are largely determined by assetisation practices. The article calls on feminist legal scholars to critically examine how financial capital, rather than gender alone, governs FemTech markets and the broader healthcare landscape.